One Biologic Comes Out on Top in Chronic Rhinosinusitis With Nasal Polyps and Asthma

(MedPage Today) -- The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma showed an advantage to dupilumab (Dupixent) over omalizumab (Xolair).
In...